Compare Stocks: COO, ALC, WST, and SOLV

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALC Alcon	$64.44 -0.2%	$70.02	$61.83 ▼ $87.64	$31.82B	0.86	1.85 million shs	568,764 shs
COO Cooper Companies	$55.79 +0.7%	$68.67	$51.01 ▼ $89.83	$10.60B	0.82	2.60 million shs	824,242 shs
SOLV Solventum	$88.93 +0.4%	$87.23	$62.38 ▼ $94.16	$15.15B	0.61	1.33 million shs	86,544 shs
WST West Pharmaceutical Services	$371.03 -0.7%	$349.98	$223.83 ▼ $386.00	$26.16B	1.14	833,354 shs	112,363 shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALC Alcon	-1.24%	-0.93%	-12.02%	-4.79%	-13.95%
COO Cooper Companies	-1.23%	+2.98%	-24.18%	-22.02%	-18.98%
SOLV Solventum	+0.41%	+1.36%	-3.20%	+11.45%	+23.55%
WST West Pharmaceutical Services	-0.38%	+2.13%	+7.32%	+6.68%	+44.21%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALC Alcon	$64.44 -0.2%	$70.02	$61.83 ▼ $87.64	$31.82B	0.86	1.85 million shs	568,764 shs
COO Cooper Companies	$55.79 +0.7%	$68.67	$51.01 ▼ $89.83	$10.60B	0.82	2.60 million shs	824,242 shs
SOLV Solventum	$88.93 +0.4%	$87.23	$62.38 ▼ $94.16	$15.15B	0.61	1.33 million shs	86,544 shs
WST West Pharmaceutical Services	$371.03 -0.7%	$349.98	$223.83 ▼ $386.00	$26.16B	1.14	833,354 shs	112,363 shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALC Alcon	-1.24%	-0.93%	-12.02%	-4.79%	-13.95%
COO Cooper Companies	-1.23%	+2.98%	-24.18%	-22.02%	-18.98%
SOLV Solventum	+0.41%	+1.36%	-3.20%	+11.45%	+23.55%
WST West Pharmaceutical Services	-0.38%	+2.13%	+7.32%	+6.68%	+44.21%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALC Alcon	2.63	Moderate Buy	$84.97	32.19% Upside
COO Cooper Companies	2.16	Hold	$71.47	28.06% Upside
SOLV Solventum	2.58	Moderate Buy	$92.80	4.63% Upside
WST West Pharmaceutical Services	2.86	Moderate Buy	$382.00	3.37% Upside

Current Analyst Ratings Breakdown

Latest COO, ALC, WST, and SOLV Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/22/2026	ALC Alcon	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$85.00
9/22/2026	WST West Pharmaceutical Services	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$365.00 ➝ $400.00
9/18/2026	COO Cooper Companies	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D) ➝ Hold (C-)
9/15/2026	ALC Alcon	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$98.00
9/14/2026	SOLV Solventum	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$95.00
9/11/2026	COO Cooper Companies	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
9/10/2026	COO Cooper Companies	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Outperform	$85.00 ➝ $75.00
9/10/2026	COO Cooper Companies	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral	$80.00 ➝ $60.00
9/10/2026	COO Cooper Companies	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Equal Weight	$66.00 ➝ $61.00
9/10/2026	COO Cooper Companies	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Negative
9/10/2026	COO Cooper Companies	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Buy	$85.00 ➝ $70.00

(Data available from 9/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALC Alcon	$10.40B	3.06	$5.37 per share	11.96	$44.55 per share	1.44
COO Cooper Companies	$4.09B	2.59	$6.11 per share	9.13	$43.80 per share	1.27
SOLV Solventum	$8.33B	1.81	$8.99 per share	9.87	$29.11 per share	3.05
WST West Pharmaceutical Services	$3.07B	8.46	$9.70 per share	38.11	$44.10 per share	8.38

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALC Alcon	$980M	$1.31	49.09	16.40	1.92	5.92%	7.29%	5.09%	11/10/2026 (Estimated)
COO Cooper Companies	$374.90M	$2.93	19.05	11.82	2.25	13.46%	10.90%	7.24%	12/3/2026 (Estimated)
SOLV Solventum	$1.56B	$8.18	10.84	12.35	1.39	17.26%	25.09%	8.78%	11/5/2026 (Estimated)
WST West Pharmaceutical Services	$493.70M	$7.81	47.44	37.33	2.60	16.98%	20.11%	14.83%	10/22/2026 (Estimated)

Latest COO, ALC, WST, and SOLV Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
10/22/2026	Q3 2026	WST West Pharmaceutical Services	$2.19	N/A	N/A	N/A	$826.00 million	N/A
9/9/2026	Q3 2026	COO Cooper Companies	$1.12	$1.15	+$0.03	$2.24	$1.10 billion	$1.07 billion
8/10/2026	Q2 2026	ALC Alcon	$0.77	$0.84	+$0.07	N/A	$2.72 billion	$2.82 billion
8/5/2026	Q2 2026	SOLV Solventum	$1.91	$2.55	+$0.64	$0.53	$2.15 billion	$2.21 billion
7/23/2026	Q2 2026	WST West Pharmaceutical Services	$2.08	$2.37	+$0.29	$2.15	$839.98 million	$872.30 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALC Alcon	N/A	N/A	N/A	N/A	4 Years
COO Cooper Companies	N/A	N/A	-100.00%	N/A	N/A
SOLV Solventum	N/A	N/A	N/A	N/A	N/A
WST West Pharmaceutical Services	$0.88	0.23%	+5.51%	11.27%	N/A

Latest COO, ALC, WST, and SOLV Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/21/2026	WST West Pharmaceutical Services	quarterly	$0.22	0.26%	7/29/2026	7/29/2026	8/5/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALC Alcon	0.19	2.09	1.30
COO Cooper Companies	0.23	1.22	0.73
SOLV Solventum	1.00	1.02	0.74
WST West Pharmaceutical Services	0.07	2.82	2.12

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ALC Alcon	53.86%
COO Cooper Companies	24.39%
SOLV Solventum	N/A
WST West Pharmaceutical Services	93.90%

Insider Ownership

Company	Insider Ownership
ALC Alcon	1.52%
COO Cooper Companies	2.08%
SOLV Solventum	0.24%
WST West Pharmaceutical Services	0.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ALC Alcon	25,942	494.62 million	487.10 million	Optionable
COO Cooper Companies	15,000	190.15 million	186.20 million	Optionable
SOLV Solventum	20,000	170.22 million	169.82 million	Optionable
WST West Pharmaceutical Services	10,800	70.38 million	69.95 million	Optionable

COO, ALC, WST, and SOLV Headlines

Recent News About These Companies

West Pharmaceutical Services, Inc. (NYSE:WST) Receives Average Rating of "Moderate Buy" from Analysts

September 25 at 2:15 AM | americanbankingnews.com

West Pharmaceutical Services, Inc. (NYSE:WST) Stock Has Consensus Target Price of $382.00

September 25 at 2:13 AM | marketbeat.com

West Pharmaceutical Services, Inc.

September 24 at 2:49 PM | fxempire.comF

State Street Corp Acquires 54,920 Shares of West Pharmaceutical Services, Inc. $WST

September 23 at 3:36 AM | marketbeat.com

West Pharmaceutical Poised to See EPS Upside to Current 2027 Wall Street Estimates, Morgan Stanley Says

September 22 at 1:03 PM | finance.yahoo.com

Nykredit A S Takes $8.78 Million Position in West Pharmaceutical Services, Inc. $WST

September 21, 2026 | marketbeat.com

Layoffs, Cyber Disruptions, Annex 1 Upgrades Might Change The Case For Investing In West (WST)

September 20, 2026 | finance.yahoo.com

What Is Drawing Attention To West Pharmaceutical Services (WST)?

September 20, 2026 | finance.yahoo.com

Bank of America Corp DE Invests $125.82 Million in West Pharmaceutical Services, Inc. $WST

September 19, 2026 | marketbeat.com

Reasons to Add West Pharmaceutical Stock to Your Portfolio Now

September 18, 2026 | zacks.com

Is West Pharmaceutical Services Stock Outperforming the Nasdaq?

September 17, 2026 | finance.yahoo.com

Annette Favorite Sells 2,500 Shares of West Pharmaceutical Services (NYSE:WST) Stock

September 17, 2026 | americanbankingnews.com

Annette Favorite Sells 2,524 Shares of West Pharmaceutical Services (NYSE:WST) Stock

September 17, 2026 | americanbankingnews.com

West Pharmaceutical Services, Inc. $WST Shares Sold by Squarepoint Ops LLC

September 17, 2026 | marketbeat.com

Is West Pharmaceutical Services Stock Outperforming the Nasdaq?

September 16, 2026 | barchart.com

West Pharmaceutical Services (NYSE:WST) VP Sells 2,500 Shares

September 16, 2026 | insidertrades.com

Insider Selling: West Pharmaceutical Services (NYSE:WST) VP Sells 2,500 Shares

September 15, 2026 | marketbeat.com

West Pharmaceutical Services (NYSE:WST) VP Sells 2,500 Shares of Stock

September 15, 2026 | marketbeat.com

Insider Selling: West Pharmaceutical Services (NYSE:WST) VP Sells $921,260.00 in Stock

September 15, 2026 | marketbeat.com

West Pharmaceutical Services, Inc. (WST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

September 14, 2026 | seekingalpha.com

WINTON GROUP Ltd Sells 30,711 Shares of West Pharmaceutical Services, Inc. $WST

September 14, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

COO, ALC, WST, and SOLV Company Descriptions

Alcon NYSE:ALC

$64.44 -0.12 (-0.19%)

As of 11:35 AM Eastern

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Cooper Companies NASDAQ:COO

$55.79 +0.41 (+0.74%)

As of 11:35 AM Eastern

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Solventum NYSE:SOLV

$88.93 +0.34 (+0.38%)

As of 11:35 AM Eastern

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

West Pharmaceutical Services NYSE:WST

$371.02 -2.58 (-0.69%)

As of 11:35 AM Eastern

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest COO, ALC, WST, and SOLV Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest COO, ALC, WST, and SOLV Earnings

Compare Dividends

Latest COO, ALC, WST, and SOLV Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

COO, ALC, WST, and SOLV Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

COO, ALC, WST, and SOLV Company Descriptions

Alcon NYSE:ALC

Cooper Companies NASDAQ:COO

Solventum NYSE:SOLV

West Pharmaceutical Services NYSE:WST

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools